Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH ANDREA MIYAHIRA
The Prostate Cancer Foundation: A Discussion with Andrea Miyahira

VIEW ALL PCF VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH KENNETH PIENTA
The Process of Metastasis in Prostate Cancer

VIEW ALL PCF VIDEOS

European Society for Medical Oncology 2018 Congress

European Society for Medical Oncology 2018 Congress

INTERVIEW WITH FRED SAAD
A Renewed Analysis of ERA 223

VIEW ALL ESMO VIDEOS

Videos
State-of-the-industry video lectures by leading urology experts
Latest Videos
Featured Videos

ORLANDO, FL USA (UroToday.com) - Renal cancer at its advanced stage is often associated with tumor thrombus that can either extend into the renal vein or the inferior vena cava. Shingo Hatakeyama presented his group’s assessment of surgical management of tumor thrombus and analysis of its benefit in patients with renal cell carcinoma.

auaThe authors identified 42 patients who had tumor thrombus in a renal vein and 43 patients who had tumor thrombus in the IVC. The authors reviewed factors that could potentially be prognostic in the treatment of these patients. To assess whether surgical treatment would benefit patients with thrombus in the major veins, the authors used propensity score matching to compare whether patients who had received surgical treatment had better overall survival than those who did not receive any therapy. After completing propensity score matching, patients who had undergone surgical treatment for their tumor thrombus had better survival than patients who had not received any surgical treatment.

The authors concluded that patients with surgical treatment for tumor thrombus might do better than patients not receiving surgery. The improved survival, however, needs to be evaluated in a larger sample, and prospectively. The authors did not discuss the reasons for which patients were not treated surgically. The results of this inquiry might increase the meaning of the potentially impactful results the authors observed in their retrospective study.

Presented by Shingo Hatakeyama, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Hirosaki, Japan

Written by Garen Abedi, MD, University of California (Irvine), and medical writer for UroToday.com

 

 

@UroToday
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe